News and Events | Page 14 | Helen & Robert Appel Alzheimer’s Disease Research Institute

BrightFocus Foundation Awards 3-Year Research Grant to the Orr Lab

In this newly funded project, the team will test the safety and efficacy of novel therapeutics that selectively target mitochondrial free radicals. They will gather vital preclinical data in different animal models of neurodegenerative disease that will inform further medicinal chemistry and therapeutic development. Specifically, the project aims to determine whether selective inhibition of mitochondrial reactive oxygen species (ROS) production can reduce neuroinflammation and neurotoxicity...

Top experts on Alzheimer’s disease speak at the sixth annual Appel Alzheimer’s Disease Research Institute Symposium

Sixth Annual Alzheimer’s Symposium Explores New Neuroscience Frontiers

As the global population ages, neurodegenerative diseases such as Alzheimer’s are becoming increasingly prevalent. But thanks to cutting-edge research from investigators at the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medicine and at academic medical institutions around the world, more is known about the disease than ever before.

...

Dr. Li Gan to Lead Appel Alzheimer’s Research Institute

Dr. Li Gan, a neuroscientist internationally acclaimed for her research into neurodegenerative diseases, has been appointed director of the Helen and Robert Appel Alzheimer’s Disease Research Institute at Weill Cornell Medicine, effective July 1.

The Appel Institute was established in 2006 with a $15 million gift from Helen and Robert Appel, vice chair of the Weill Cornell Medicine Board of Overseers....

Fifth Annual Appel Alzheimer's Disease Research Institute Symposium to be held on October 17, 2017

Please join us for our Fifth Annual Appel Alzheimer's Disease Research Institute Symposium: The Aging Brain to be held on Tuesday, October 17, 2017 from 8:30 a.m. - 12:00 p.m. at the Belfer Research Building on 413 East 69th Street, New York, NY. This year's guest speakers will include Dr. Richard M. Ransohoff, Vice President of Neuroimmunology at Biogen Pharmaceuticals in Cambridge, Massachusetts and Dr. Carla J. Shatz, Director of Bio-X and Professor of Biology and Neurobiology at Stanford...

‹ previous
14 of 14